The growth and success of the Company's business was reflected by the increase in the Company's share price and market capitalisation during the year. The growth of the business was further recognised in September 2014, when the Company was admitted to the ASX300 index.
Donaco International Limited (ASX:DNA) is pleased to announce that it has signed an exclusive term sheet, and is currently conducting due diligence, for a proposed material acquisition of a significant gaming and hospitality business in Cambodia.
The most important development was the opening of the Aristo International Hotel in May 2014. Through this brand-new resort complex in northern Vietnam, Donaco now has a greatly expanded leisure and entertainment offering. This magnificent new property will underpin growth in the year ahead.
As part of the spin-off, Donaco sought a ruling from the Australian Taxation Office (ATO) on the taxation implications for Australian resident shareholders who hold their shares on capital account.
Donaco International Limited (ASX:DNA) refers to the recent spin-off of iSentric Limited (iSentric), which now trades on the ASX under the code ICU. The ICU shares previously had the code OMI.
The financial statements cover Donaco International Limited as a consolidated entity consisting of Donaco International Limited and its subsidiaries. The financial statements are presented in Australian dollars, which is Donaco International Limited's functional and presentation currency.
Donaco International Limited (ASX:DNA) announces that the ASX has advised that iSentric Limited (iSentric) has met the conditions for re-admission to quotation on the ASX.
